225 related articles for article (PubMed ID: 10523046)
1. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.
Engström G; Alling C; Blennow K; Regnéll G; Träskman-Bendz L
Eur Neuropsychopharmacol; 1999 Sep; 9(5):399-405. PubMed ID: 10523046
[TBL] [Abstract][Full Text] [Related]
2. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
Roy A; Ninan P; Mazonson A; Pickar D; Van Kammen D; Linnoila M; Paul SM
Psychol Med; 1985 May; 15(2):335-40. PubMed ID: 2410941
[TBL] [Abstract][Full Text] [Related]
3. Monoamine metabolites in CSF and suicidal behavior.
Träskman L; Asberg M; Bertilsson L; Sjöstrand L
Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
[TBL] [Abstract][Full Text] [Related]
4. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels.
Placidi GP; Oquendo MA; Malone KM; Huang YY; Ellis SP; Mann JJ
Biol Psychiatry; 2001 Nov; 50(10):783-91. PubMed ID: 11720697
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid monoamine metabolite concentrations in suicide attempt: A meta-analysis.
Sharma R; Tikka SK; Yadav AK; Bhute AR; Dhamija P; Bastia BK
Asian J Psychiatr; 2021 Aug; 62():102711. PubMed ID: 34090249
[TBL] [Abstract][Full Text] [Related]
6. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.
Lindqvist D; Janelidze S; Hagell P; Erhardt S; Samuelsson M; Minthon L; Hansson O; Björkqvist M; Träskman-Bendz L; Brundin L
Biol Psychiatry; 2009 Aug; 66(3):287-92. PubMed ID: 19268915
[TBL] [Abstract][Full Text] [Related]
8. The relationship between CSF HVA/5-HIAA ratio and suicide intent in suicide attempters.
Jokinen J; Nordström AL; Nordström P
Arch Suicide Res; 2007; 11(2):187-92. PubMed ID: 17453696
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
10. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
[TBL] [Abstract][Full Text] [Related]
11. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
12. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
[TBL] [Abstract][Full Text] [Related]
13. CSF biomarkers in suicide attempters--a principal component analysis.
Lindqvist D; Janelidze S; Erhardt S; Träskman-Bendz L; Engström G; Brundin L
Acta Psychiatr Scand; 2011 Jul; 124(1):52-61. PubMed ID: 21198458
[TBL] [Abstract][Full Text] [Related]
14. CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence.
Sher L; Oquendo MA; Grunebaum MF; Burke AK; Huang YY; Mann JJ
Eur Neuropsychopharmacol; 2007 Jan; 17(1):12-5. PubMed ID: 16762535
[TBL] [Abstract][Full Text] [Related]
15. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid monoamine metabolites and suicide.
Jokinen J; Nordström AL; Nordström P
Nord J Psychiatry; 2009; 63(4):276-9. PubMed ID: 19034712
[TBL] [Abstract][Full Text] [Related]
17. HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters.
Jokinen J; Samuelsson M; Nordström AL; Nordström P
J Affect Disord; 2008 Nov; 111(1):119-24. PubMed ID: 18342374
[TBL] [Abstract][Full Text] [Related]
18. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
von Holst H; Lindquist C; Sedvall G
Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
[TBL] [Abstract][Full Text] [Related]
19. CSF metabolites in borderline personality disorder compared with normal controls.
Gardner DL; Lucas PB; Cowdry RW
Biol Psychiatry; 1990 Aug; 28(3):247-54. PubMed ID: 1696137
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
